In unstressed cells, including MM.1 S.5B cells, we could generate DDI2-deficient populations with similar efficacy as control cells expressing a sgRNA targeting luciferase, suggesting that DDI2 is not an essential protease in multiple myeloma. The gene discussed is DDI2; the disease is plasma cell myeloma.